REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr Peretti Company Limited (Thailand)

Main Activities: Research and Development in Nanotechnology
Full name: Dr Peretti Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dr Peretti Company Limited is a company based in Thailand, with its head office in Bangkok , Special Governed District of. The company operates in the Research and Development in Nanotechnology sector. It was established on May 22, 2026. Dr Peretti Company Limited currently employs 13 (2024) people. There was a net sales revenue increase of 37.36% reported in Dr Peretti Company Limited’s latest financial highlights for 2024. During that time, Dr Peretti Company Limited’s total assets grew by 108.56%. In, 2024, the company’s net profit margin increased by 18.43%.

Headquarters
228,230 Mahesak Road
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10500

Contact Details: Purchase the Dr Peretti Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Dr Peretti Company Limited report to view the information.
Financial Auditors:
Purchase the Dr Peretti Company Limited report to view the information.
Incorporation Date:
May 22, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Dr Peretti Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
37.36%
Total Operating Revenue
37.17%
Operating Profit
139.85%
EBITDA
139.85%
Net Profit/Loss for the Period
147.15%
Total Assets
108.56%
Total Equity
107.77%
Operating Profit Margin
22.43%
Net Profit Margin
18.43%
Return on Equity (ROE)
11.22%
Quick Ratio
0.68%
Cash Ratio
-2.93%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?